Home Cart 0 Sign in  

[ CAS No. 1014-23-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 1014-23-9
Chemical Structure| 1014-23-9
Structure of 1014-23-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1014-23-9 ]

Related Doc. of [ 1014-23-9 ]

Alternatived Products of [ 1014-23-9 ]

Product Details of [ 1014-23-9 ]

CAS No. :1014-23-9 MDL No. :MFCD00085148
Formula : C9H6N2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :JJFHVOMPLSSUEC-UHFFFAOYSA-N
M.W : 190.16 Pubchem ID :2737068
Synonyms :

Calculated chemistry of [ 1014-23-9 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 11
Fraction Csp3 : 0.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 50.76
TPSA : 71.85 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.16 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.62
Log Po/w (XLOGP3) : 1.83
Log Po/w (WLOGP) : 2.25
Log Po/w (MLOGP) : 0.78
Log Po/w (SILICOS-IT) : 0.22
Consensus Log Po/w : 1.34

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.62
Solubility : 0.455 mg/ml ; 0.00239 mol/l
Class : Soluble
Log S (Ali) : -2.96
Solubility : 0.209 mg/ml ; 0.0011 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.14
Solubility : 0.138 mg/ml ; 0.000726 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.24

Safety of [ 1014-23-9 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P301+P310-P305+P351+P338 UN#:2811
Hazard Statements:H301-H319 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1014-23-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1014-23-9 ]
  • Downstream synthetic route of [ 1014-23-9 ]

[ 1014-23-9 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 1014-23-9 ]
  • [ 1008-95-3 ]
YieldReaction ConditionsOperation in experiment
90% With hydrogenchloride; tin In ethanol; water at 20℃; for 2 h; To a solution of 5-(4-nitro-phenyl)-oxazole (500mg, 2.6mmol) in ethanol (10ml) was added tin (620mg, 5.2mmol), followed by dropwise addition of concentrated hydrochloric acid (ImI) and then the reaction was stirred at room temperature for 2hr. The reaction mixture was filtered and the filtrate evaporated to dryness. The resultant residue was diluted with water (10ml), basified with saturated bicarbonate solution, then extracted with ethyl acetate. The organic layer was separated, washed with water, dried and concentrated to dryness to yield 4-oxazol-5-yl-phenylamine (380mg, 90percent) as solid.
Reference: [1] Patent: WO2006/123145, 2006, A1, . Location in patent: Page/Page column 66-67
[2] Patent: EP1612204, 2006, A1, . Location in patent: Page/Page column 20
  • 2
  • [ 1014-23-9 ]
  • [ 7439-89-6 ]
  • [ 1008-95-3 ]
Reference: [1] Patent: US2004/204386, 2004, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1014-23-9 ]

Aryls

Chemical Structure| 89808-77-5

[ 89808-77-5 ]

5-(3-Nitrophenyl)oxazole

Similarity: 0.98

Chemical Structure| 89808-75-3

[ 89808-75-3 ]

5-(2-Nitrophenyl)oxazole

Similarity: 0.93

Chemical Structure| 13576-56-2

[ 13576-56-2 ]

5-(4-Nitrophenyl)oxazol-2-amine

Similarity: 0.89

Chemical Structure| 31699-02-2

[ 31699-02-2 ]

2-Methyl-5-(4-nitrophenyl)oxazole

Similarity: 0.89

Chemical Structure| 1008-95-3

[ 1008-95-3 ]

4-(1,3-Oxazol-5-yl)aniline

Similarity: 0.81

Nitroes

Chemical Structure| 89808-77-5

[ 89808-77-5 ]

5-(3-Nitrophenyl)oxazole

Similarity: 0.98

Chemical Structure| 89808-75-3

[ 89808-75-3 ]

5-(2-Nitrophenyl)oxazole

Similarity: 0.93

Chemical Structure| 13576-56-2

[ 13576-56-2 ]

5-(4-Nitrophenyl)oxazol-2-amine

Similarity: 0.89

Chemical Structure| 31699-02-2

[ 31699-02-2 ]

2-Methyl-5-(4-nitrophenyl)oxazole

Similarity: 0.89

Chemical Structure| 198821-78-2

[ 198821-78-2 ]

5-(2-Methoxy-4-nitrophenyl)oxazole

Similarity: 0.81

Related Parent Nucleus of
[ 1014-23-9 ]

Oxazoles

Chemical Structure| 89808-77-5

[ 89808-77-5 ]

5-(3-Nitrophenyl)oxazole

Similarity: 0.98

Chemical Structure| 89808-75-3

[ 89808-75-3 ]

5-(2-Nitrophenyl)oxazole

Similarity: 0.93

Chemical Structure| 13576-56-2

[ 13576-56-2 ]

5-(4-Nitrophenyl)oxazol-2-amine

Similarity: 0.89

Chemical Structure| 31699-02-2

[ 31699-02-2 ]

2-Methyl-5-(4-nitrophenyl)oxazole

Similarity: 0.89

Chemical Structure| 1008-95-3

[ 1008-95-3 ]

4-(1,3-Oxazol-5-yl)aniline

Similarity: 0.81